{"database": "lobbying", "table": "lobbying_activities", "rows": [[2145354, "a8aa941e-19d9-465f-90e7-57d2eca8fdae", "Q2", "KATE MOSS", 25988, "CVS HEALTH", 2018, "second_quarter", "PHA", "Legislation impacting PBMs and drug pricing", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2018-07-16T14:26:07.193000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2145354"], "units": {}, "query_ms": 0.3790520131587982, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}